Protease activity on dysplastic leukoplakia sites
- Conditions
- Oral leukoplakia
- Registration Number
- NL-OMON23952
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 48
Inclusion Criteria
OL and OSCC groups (group A and B): all new patients (age ? 18 years) diagnosed with oral leukoplakia or OSCC at the Amsterdam UMC location VUmc
Control group (group C): Volunteers in the control group will be age and sex matched compared to the OL and OSCC groups. Healthy is defined as an American Society of Anesthetists score I and without medication use except for oral contraception and no OL and/or OSCC
Exclusion Criteria
Age < 18 years
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Protease activity in saliva and saliva biofilm
- Secondary Outcome Measures
Name Time Method